maintenance dose for tirzepatide dosing chart I"ll share in case any newbies have trouble figuring out their units. I store this sheet with my needles so I don't do freak-out math in the moment Staying on High Dose Nearly

Table 13: Results at Week 52 in a Trial Comparing TRESIBA to Insulin Glargine U-100 in Adult Patients with Type 2 Diabetes Mellitus Receiving Insulin Aspart at Mealtimes and OADs* Study I: TRESIBA Administered at Any Time Each Day as an Add-on to One or Two of the Following Oral Agents: Metformin, Sulfonylurea, or Pioglitazone in Adult Patients The efficacy of TRESIBA was evaluated in a 26-week randomized, open-label, multicenter trial in 447 patients with type 2 diabetes mellitus inadequately controlled on one or more oral antidiabetic agent (OADs) at baseline

Ethical Issues The study was conducted following the Declaration of Helsinki and approved by the Institutional and Regional Ethical Committees of Faculty of Medicine, Tanta University (reference number: 36264PR1087/2/25) and had Clinical trial registration from Pan African Clinical Trial Registry (PACTR202504698770932)

Start Your Medical Weight Loss Journey Today Ready to take control of your health

GLP-1 medications currently available on the market for weight loss include: Weekly semaglutide injections (Wegovy) Daily semaglutide tablets (Wegovy) Weekly tirzepatide injections (Zepbound) Daily liraglutide injections (Saxenda) How Do GLP-1s Work